REGENXBIO
RGNX
£6.30
Share price
-4.32%
Change (1 day)
-43.67%
Change (1 year)
Categories
REGENXBIO (RGNX) Fails to deliver data
Key failure to deliver metrics for REGENXBIO:
- Last SEC data release: 2025-06-30
- Last 15 days FTD volume: £0.33 M
- Last 3 months FTD volume: £0.71 M
- Last year FTD volume: £0.71 M
A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.
Failures to deliver for REGENXBIO (RGNX) - 3 months history
Number of shares, 3 months chart
Biweekly Failures to deliver volume for REGENXBIO (RGNX) - since 2015
Volume in USD (price x number of shares), data since 2015REGENXBIO (RGNX) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2025 | £0.86 M | -91.62% |
| 2024 | £10.37 M | 353.19% |
| 2023 | £2.28 M | -33.57% |
| 2022 | £3.44 M | -81.19% |
| 2021 | £18.32 M | 424.91% |
| 2020 | £3.49 M | -60.92% |
| 2019 | £8.93 M | -45.69% |
| 2018 | £16.44 M | 27.78% |
| 2017 | £12.86 M | 340.15% |
| 2016 | £2.92 M | -55.46% |
| 2015 | £6.56 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3 months) | FTD volume (1 year) | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | £2.35 M | £10.02 M | 🇺🇸 USA |